Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

Clinical trial NCT07629206 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07629206
Sponsor: IceCure Medical Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Low-Risk, Early Stage Breast Cancer

Start date: 2026-07-17
Primary completion: 2034-07-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.